# Botulinum Toxin A for Herpes Labialis

> **NCT01225341** · NA · TERMINATED · sponsor: **DeNova Research** · enrollment: 20 (actual)

## Conditions studied

- Herpes Labialis

## Interventions

- **DRUG:** onabotulinumtoxinA
- **OTHER:** Bacteriostatic normal saline

## Key facts

- **NCT ID:** NCT01225341
- **Lead sponsor:** DeNova Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Too many patients withdrew/lost to follow up
- **Last updated:** 2020-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225341, "Botulinum Toxin A for Herpes Labialis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01225341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*